Bank of America
CASI

Bank of America’s CASI Pharmaceuticals CASI Stock Holding History

Bank of America’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,935
Closed -$16.9K – 5894
2025
Q4 		$16.9K Sell
19,935
-234,949
-92% -$304K ﹤0.01% 6081
2025
Q3 		$423K Buy
254,884
+242,823
+2,013% +$433K ﹤0.01% 5892
2025
Q2 		$14.2K Buy
12,061
+11,995
+18,174% +$22K ﹤0.01% 7122
2025
Q1 		$143 Buy
66
+38
+136% +$93 ﹤0.01% 7761
2024
Q4 		$79 Hold
28
– – ﹤0.01% 7792
2024
Q3 		$172 Sell
28
-25
-47% -$162 ﹤0.01% 7602
2024
Q2 		$292 Hold
53
– – ﹤0.01% 7474
2024
Q1 		$191 Buy
53
+50
+1,667% +$269 ﹤0.01% 7349
2023
Q4 		$21 Hold
3
– – ﹤0.01% 7641
2023
Q3 		$8 Sell
3
-658
-100% -$1.56K ﹤0.01% 7634
2023
Q2 		$1.65K Buy
661
+658
+21,933% +$1.77K ﹤0.01% 7172
2023
Q1 		$7 Sell
3
-9
-75% -$17 ﹤0.01% 7656
2022
Q4 		$21 Buy
12
+9
+300% +$18 ﹤0.01% 7975
2022
Q3 		$0 Hold
3
– – ﹤0.01% 7852
2022
Q2 		$0 Sell
3
-23
-88% -$100 ﹤0.01% 8036
2022
Q1 		$0 Sell
26
-11,766
-100% -$92.4K ﹤0.01% 8284
2021
Q4 		$94K Buy
11,792
+6,206
+111% +$61.8K ﹤0.01% 6910
2021
Q3 		$67K Sell
5,586
-1,431
-20% -$19.4K ﹤0.01% 6909
2021
Q2 		$109K Buy
7,017
+1,141
+19% +$19.2K ﹤0.01% 6473
2021
Q1 		$141K Buy
5,876
+3,539
+151% +$99.4K ﹤0.01% 6246
2020
Q4 		$69K Buy
2,337
+947
+68% +$20.6K ﹤0.01% 6169
2020
Q3 		$21K Sell
1,390
-459
-25% -$8.65K ﹤0.01% 6270
2020
Q2 		$46K Buy
1,849
+941
+104% +$20.4K ﹤0.01% 6014
2020
Q1 		$19K Sell
908
-749
-45% -$17.9K ﹤0.01% 6189
2019
Q4 		$51K Sell
1,657
-618
-27% -$20K ﹤0.01% 6255
2019
Q3 		$76K Buy
2,275
+548
+32% +$17.6K ﹤0.01% 6170
2019
Q2 		$55K Buy
1,727
+832
+93% +$26.6K ﹤0.01% 6265
2019
Q1 		$27K Sell
895
-2,000
-69% -$69.7K ﹤0.01% 6408
2018
Q4 		$117K Buy
2,895
+1,652
+133% +$62.6K ﹤0.01% 5822
2018
Q3 		$58K Buy
1,243
+484
+64% +$33.8K ﹤0.01% 6144
2018
Q2 		$63K Buy
759
+89
+13% +$6.01K ﹤0.01% 6016
2018
Q1 		$28K Buy
670
+570
+570% +$21.3K ﹤0.01% 6270
2017
Q4 		$3K Sell
100
-14
-12% -$380 ﹤0.01% 6802
2017
Q3 		$2K Sell
114
-3
-3% -$35 ﹤0.01% 6852
2017
Q2 		$1K Buy
117
+3
+3% +$32 ﹤0.01% 6800
2017
Q1 		$2K Hold
114
– – ﹤0.01% 6783
2016
Q4 		$1K Sell
114
-242
-68% -$3.31K ﹤0.01% 6894
2016
Q3 		$4K Buy
356
+304
+585% +$3.34K ﹤0.01% 6666
2016
Q2 		$1K Buy
52
+33
+174% +$416 ﹤0.01% 6981
2016
Q1 		$0 Sell
19
-4
-17% -$39 ﹤0.01% 7017
2015
Q4 		$0 Hold
23
– – ﹤0.01% 7299
2015
Q3 		$0 Sell
23
-9
-28% -$130 ﹤0.01% 7220
2015
Q2 		$1K Hold
32
– – ﹤0.01% 7114
2015
Q1 		$0 Hold
32
– – ﹤0.01% 7087
2014
Q4 		$0 Sell
32
-3
-9% -$47 ﹤0.01% 7690
2014
Q3 		$1K Buy
+35
New +$622 ﹤0.01% 7869
2014
Q2 		– Sell
-35
Closed -$1K – 8020
2014
Q1 		$1K Hold
35
– – ﹤0.01% 7610
2013
Q4 		$1K Hold
35
– – ﹤0.01% 7717
2013
Q3 		$1K Sell
35
-10
-22% -$190 ﹤0.01% 7723
2013
Q2 		$1K Buy
+45
New +$873 ﹤0.01% 7582

Other funds holding CASI

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of America's CASI Position: Q1 2026 in Review

Bank of America sold out of CASI Pharmaceuticals (CASI) in Q1 2026, closing a stake of 19,935 shares — an estimated $16.9K sold.

Bank of America first reported a position in CASI in Q2 2013 and held it in 50 quarters. The position peaked at $423K in Q3 2025. 1 fund tracked by Wall St. Rank holds CASI as of Q1 2026.

  • Bank of America reported no remaining CASI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 19,935 CASI Pharmaceuticals shares in Q1 2026, an estimated $16.9K.
  • Bank of America first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 50 quarters.
  • Bank of America's CASI Pharmaceuticals position peaked at $423K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.